
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Atomoxetine Hydrochloride | FAERS: 2 | US FAERS | |
| 2 | Adzenys XR-ODT | FAERS: 1 | US FAERS | |
| 3 | Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination | FAERS: 1 | US FAERS | |
| 4 | Baclofen | FAERS: 1 | US FAERS | |
| 5 | Bosentan | FAERS: 1 | US FAERS | |
| 6 | Ethylene Glycol | FAERS: 1 | US FAERS | |
| 7 | Everolimus | FAERS: 1 | US FAERS | |
| 8 | Lorazepam | FAERS: 1 | US FAERS | |
| 9 | NuvaRing | FAERS: 1 | OFFSIDES US FAERS | |
| 10 | Pregabalin | FAERS: 1 | US FAERS | |
| 11 | Tenofovir | FAERS: 1 | US FAERS | |
| 12 | etonogestrel | FAERS: 1 | US FAERS | |
| 13 | rofecoxib | FAERS: 1 | US FAERS | |
| 14 | Atomoxetine Hydrochloride | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.